Adela Cota‐Gomez

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “Nrf2 Activator PB125® as a Potential Therapeutic Agent against COVID-19”.

Nrf2 Activator PB125® as a Potential Therapeutic Agent against COVID-19

Antioxidants(2020)10.3390/antiox9060518

N/A

0DataRank · unranked

109 citations

Brooks M. Hybertson, Adela Cota‐Gomez, Kara Geraci, Bifeng Gao, Joe M. McCord

Nrf2 Activator PB125 ® as a Potential Therapeutic Agent Against COVID-19

bioRxiv (Cold Spring Harbor Laboratory)(2020)10.1101/2020.05.16.099788

N/A

0DataRank · unranked

35 citations

Brooks M. Hybertson, Adela Cota‐Gomez, Bifeng Gao, Joe M. McCord

Nrf2 activator PB125® as a carnosic acid-based therapeutic agent against respiratory viral diseases, including COVID-19

Free Radical Biology and Medicine(2021)10.1016/j.freeradbiomed.2021.05.033

N/A

0DataRank · unranked

17 citations

Brooks M. Hybertson, Adela Cota‐Gomez, Bifeng Gao, Joe M. McCord